CAREDX, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CAREDX, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.25M, a 20.99% increase year-over-year.
- CAREDX, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $109.00K, a 96.43% decline year-over-year.
- CAREDX, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $232.00K, a 92.73% decline year-over-year.
- CAREDX, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.03M, a 736.59% increase year-over-year.
- CAREDX, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $5.72M, a 35.96% decline from fiscal 2024.
- CAREDX, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $8.94M, a 7346.67% increase from fiscal 2023.
- CAREDX, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $120.00K, a 95.07% decline from fiscal 2022.
- CAREDX, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $2.44M, a 80.94% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $109.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $5.72M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $232.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.03M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $3.05M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $8.94M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $3.19M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $123.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $8.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $120.00K 10-K · filed 2026-02-25 | |
| 2023-09-30 | $99.00K 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $6.00K 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $2.44M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $139.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $413.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $1.60M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $12.78M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $1.90M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $6.83M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $2.19M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $8.01M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $1.65M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.96M 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $155.00K 10-Q · filed 2021-10-28 | |
| 2019-12-31 | $3.55M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $476.00K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $1.41M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $1.36M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $1.48M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $411.00K 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $98.00K 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $80.00K 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $262.00K 10-K · filed 2020-02-28 | |
| 2016-12-31 | $19.00K 10-K · filed 2019-03-06 | |
| 2015-12-31 | $46.00K 10-K · filed 2018-03-22 | |
| 2014-12-31 | $19.00K 10-K · filed 2017-04-21 | |
| 2012-12-31 | $10.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |